[go: up one dir, main page]

AR078221A1 - Sintesis de mesilato de 1-amino-1,3,3,5,5-pentametil ciclohexano y composiciones farmaceuticas - Google Patents

Sintesis de mesilato de 1-amino-1,3,3,5,5-pentametil ciclohexano y composiciones farmaceuticas

Info

Publication number
AR078221A1
AR078221A1 ARP100101277A ARP100101277A AR078221A1 AR 078221 A1 AR078221 A1 AR 078221A1 AR P100101277 A ARP100101277 A AR P100101277A AR P100101277 A ARP100101277 A AR P100101277A AR 078221 A1 AR078221 A1 AR 078221A1
Authority
AR
Argentina
Prior art keywords
amino
acetate
methyl
pentamethyl cyclohexane
pentamethyl
Prior art date
Application number
ARP100101277A
Other languages
English (en)
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of AR078221A1 publication Critical patent/AR078221A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/04—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups
    • C07C209/14—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups
    • C07C209/16—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of functional groups by amino groups by substitution of hydroxy groups or of etherified or esterified hydroxy groups with formation of amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68—Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/84—Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82—Purification; Separation; Stabilisation; Use of additives
    • C07C209/86—Separation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un procedimiento para elaborar mesilato de 1-amino-1,3,3,5,5-pentametil ciclohexano que comprende el paso (i): hacer reaccionar 1-amino-1,3,3,5,5-pentametil ciclohexano con ácido metano sulfonico en un solvente o en una mezcla de dos o más solventes seleccionados entre anisol, cumeno; pentano, hexano, heptano, isooctano; acetato de metilo, acetato de propilo, acetato de isopropilo, acetato de n-butilo, acetato de isobutilo; metil etil cetona, metil isopropil cetona, metil isobutil cetona; sulfoxido de dimetilo; tetrahidrofurano, metiltetrahidrofurano, 1 ,1-dietoxipropano, 1 ,1-dimetoximetano y 2,2-dimetoxipropano. Reivindicacion 21: Una composicion farmacéutica que comprende el 1-amino-1 ,3,3,5,5-pentametil ciclohexano segun la reivindicacion 17; o los cristales de mesilato de 1-amino- 1 ,3,3,5,5-pentametil ciclohexano segun la reivindicacion 19; o las partículas de mesilato de 1-amino-1 ,3,3,5,5-pentametil ciclohexano segun la reivindicacion 20 y, opcionalmente, al menos un excipiente farmacéuticamente aceptable.
ARP100101277A 2009-04-17 2010-04-16 Sintesis de mesilato de 1-amino-1,3,3,5,5-pentametil ciclohexano y composiciones farmaceuticas AR078221A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21401509P 2009-04-17 2009-04-17
EP09005471 2009-04-17

Publications (1)

Publication Number Publication Date
AR078221A1 true AR078221A1 (es) 2011-10-26

Family

ID=40942504

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100101277A AR078221A1 (es) 2009-04-17 2010-04-16 Sintesis de mesilato de 1-amino-1,3,3,5,5-pentametil ciclohexano y composiciones farmaceuticas

Country Status (15)

Country Link
US (1) US8784847B2 (es)
EP (1) EP2419402B1 (es)
JP (1) JP6076736B2 (es)
KR (1) KR20120006059A (es)
CN (1) CN102438981B (es)
AR (1) AR078221A1 (es)
AU (1) AU2010237271B2 (es)
BR (1) BRPI1011322A2 (es)
CA (1) CA2758756A1 (es)
ES (1) ES2605582T3 (es)
IL (1) IL215352A0 (es)
MX (1) MX2011010750A (es)
RU (1) RU2513090C2 (es)
TW (1) TW201040130A (es)
WO (1) WO2010118889A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013072050A1 (en) 2011-11-15 2013-05-23 Merz Pharma Gmbh & Co. Kgaa Neramexane mesylate monohydrate and anhydrate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0656349T3 (da) * 1993-12-03 1998-06-02 Ono Pharmaceutical Co Amidinophenolderivater med inhiberende virkning på phospholipase A2
CA2241904C (en) 1996-01-02 2004-12-21 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
DK1009732T3 (da) 1997-06-30 2003-09-22 Merz Pharma Gmbh & Co Kgaa 1-Amino-alkylcyclohexan NMDA receptor antagonister
US7019140B2 (en) 2002-03-15 2006-03-28 Antibioticos S.P.A. Process for the synthesis of pergolide
FR2869913B1 (fr) * 2004-05-04 2009-01-23 Appia Composition tensioactive, procede de preparation et cosmetique comprenant cette composition
US20060002999A1 (en) * 2004-06-17 2006-01-05 Forest Laboratories, Inc. Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
JP2008525501A (ja) * 2004-12-23 2008-07-17 ゼノポート，インコーポレイティド セリンアミノ酸誘導のプロポフォールのプロドラッグ、その使用及び結晶体
EP1858501A1 (en) 2005-03-07 2007-11-28 Michael Hermanussen Nmda receptor antagonists in the medical intervention of metabolic disorders
WO2006094574A1 (de) 2005-03-11 2006-09-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zum herstellen einer nanostruktur auf einem substrat
US20070141148A1 (en) 2005-11-30 2007-06-21 Merz Pharma Gmbh & Co. Kgaa Neramexane MR matrix tablet
TWI403493B (zh) * 2005-12-05 2013-08-01 Xenoport Inc 左旋多巴前藥的甲磺酸鹽，其組成物，及其用途
EP2046787B1 (en) * 2006-08-01 2011-04-06 Glaxo Group Limited Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors

Also Published As

Publication number Publication date
BRPI1011322A2 (pt) 2018-09-18
ES2605582T3 (es) 2017-03-15
EP2419402A1 (en) 2012-02-22
WO2010118889A1 (en) 2010-10-21
CN102438981B (zh) 2015-04-22
US8784847B2 (en) 2014-07-22
EP2419402B1 (en) 2016-08-31
AU2010237271A1 (en) 2011-10-20
CA2758756A1 (en) 2010-10-21
MX2011010750A (es) 2011-10-24
CN102438981A (zh) 2012-05-02
HK1164833A1 (en) 2012-09-28
TW201040130A (en) 2010-11-16
JP2012524036A (ja) 2012-10-11
RU2513090C2 (ru) 2014-04-20
RU2011146633A (ru) 2013-05-27
JP6076736B2 (ja) 2017-02-08
KR20120006059A (ko) 2012-01-17
IL215352A0 (en) 2011-12-29
AU2010237271B2 (en) 2015-08-20
US20120100184A1 (en) 2012-04-26

Similar Documents

Publication Publication Date Title
AR089578A1 (es) Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion
EA201391758A1 (ru) Спрессованная сердцевина для фармацевтической композиции, содержащая органические кислоты
AR082566A1 (es) Formulaciones liquidas de st-246 y metodos relacionados, proceso
ECSP088975A (es) Nuevos análagos de piridina
UA100866C2 (ru) Продукт твердой дисперсии, который содержит соединения на основе n-арилмочевины
EA200901277A1 (ru) Фармацевтические составы, содержащие пропиленгликольгидрат дапаглифлозина
EA201171216A1 (ru) Фенилацетат l-орнитина и способы его получения
WO2010109334A3 (en) Thienopyrimidinedione derivatives as trpa1 modulators
WO2007086078A3 (en) Novel pharmaceutical compositions and process of preparation thereof
WO2011015522A3 (en) Process for the manufacture of pharmaceutically active compounds
DK2207526T3 (da) Fremgangsmåde til fremstilling af et farmaceutisk produkt omfattende citronsyre, magnesiumoxid, kaliumbicarbonat og natriumpicosulfat, farmaceutisk sammensætning omfattende granuler opnået ved sådanne fremgangsmåder og mellemprodukter deraf.
CO6761374A2 (es) Derivados de heteroarilo como moduladores de nachr alfa 7
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
AR069225A1 (es) Procedimiento de preparacion de compuestos morfinicos
ES2505475T1 (es) Procedimiento de preparación de alcoxi-hidroxibenzaldehído sensiblemente exento de alquil-alcoxi-hidroxibenzaldehído
BR112014011327A2 (pt) copolímeros em tribloco de estireno-siloxano como membranas para transporte seletivo de álcoois e outros compostos orgânicos em misturas aquosas
WO2011089126A3 (en) Novel retigabine composition
DOP2024000239A (es) Compuestos amido heteroaromáticos útiles en el tratamiento de enfermedades hepáticas
MX2010004291A (es) Producto de dispersion solida de farmacos basados en n-aril urea.
UY26720A1 (es) Derivados del pirrol
AR078221A1 (es) Sintesis de mesilato de 1-amino-1,3,3,5,5-pentametil ciclohexano y composiciones farmaceuticas
NZ628796A (en) Pure erlotinib
WO2009151498A3 (en) Memantine formulations
NZ599268A (en) Pharmaceutical compositions of rhein or diacerein made by wet granulation process
CL2008001325A1 (es) Compuestos derivados de pirazol-piridinona; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar inflamacion, enfermedad de paget, osteoartritis, alzheimer, entre otras enfermedades.

Legal Events

Date Code Title Description
FB Suspension of granting procedure